Covered recipient · General Payments record
MICHELLE E BARBEE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,161.47
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $426.62 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UROGEN PHARMA, INC. | $123.75 | 2 |
| Medtronic, Inc. | $94.62 | 4 |
| ABBVIE INC. | $45.31 | 3 |
| Sumitomo Pharma America, Inc. | $43.37 | 2 |
| Janssen Biotech, Inc. | $31.08 | 1 |
| Tempus AI, Inc | $21.04 | 1 |
| Teleflex LLC | $19.77 | 1 |
| PFIZER INC. | $19.18 | 1 |
| PROCEPT BioRobotics Corporation | $14.82 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.11 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106480872 | CMS |
| ABBVIE INC. | $15.68 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106480874 | CMS |
| ABBVIE INC. | $16.52 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106480876 | CMS |
| Boston Scientific Corporation | $13.68 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092477003 | CMS |
| Janssen Biotech, Inc. | $31.08 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078811677 | CMS |
| Medtronic, Inc. | $45.44 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116918860 | CMS |
| Medtronic, Inc. | $13.95 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116918862 | CMS |
| Medtronic, Inc. | $20.20 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116918866 | CMS |
| Medtronic, Inc. | $15.03 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116918864 | CMS |
| PFIZER INC. | $19.18 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131812712 | CMS |
| PROCEPT BioRobotics Corporation | $14.82 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144032214 | CMS |
| Sumitomo Pharma America, Inc. | $29.22 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148943259 | CMS |
| Sumitomo Pharma America, Inc. | $14.15 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148943261 | CMS |
| Teleflex LLC | $19.77 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142078324 | CMS |
| Tempus AI, Inc | $21.04 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150178413 | CMS |
| UROGEN PHARMA, INC. | $87.14 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137920533 | CMS |
| UROGEN PHARMA, INC. | $36.61 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137933644 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.